The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals-Reference-Cited by-同舟云学术

The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals

Published:2020-12-04 Issue:4 Volume:62 Page:438-445
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

van Dongen Guus A.M.S.,Beaino Wissam,Windhorst Albert D.,Zwezerijnen Gerben J.C.,Oprea-Lager Daniela E.,Hendrikse N. Harry,van Kuijk Cornelis,Boellaard Ronald,Huisman Marc C.,Vugts Danielle J.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference57 articles.

1. How to improve R&D productivity: the pharmaceutical industry's grand challenge

2. 2018 FDA approvals hit all time high—but average value slips again;Baedecker;Nat Rev Drug Discov.,2019

3. Biopharmaceutical benchmarks 2018

4. Antibodies to watch in 2019

5. The endless frontier? The recent increase of R&D productivity in pharmaceuticals;Pammolli;J Transl Med.,2020

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [89Zr]ZrCl4 for direct radiolabeling of DOTA-based precursors;Nuclear Medicine and Biology;2024-09

2. The role of CD8 PET imaging in guiding cancer immunotherapy;Frontiers in Immunology;2024-07-12

3. 89Zr-immunoPET-guided selection of a CD33xIL15 fusion protein optimized for antitumor immune cell activation and in vivo tumour retention in acute myeloid leukaemia;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-11

4. Construction of [⁸⁹Zr]Zr-Labeled HuL13 for ImmunoPET Imaging of LAG-3 Checkpoint Expression on Tumor-Infiltrating T Cells;Molecular Pharmaceutics;2024-06-28

5. Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-18